Sanofi CEO going to US, Bayer CEO going
This article was originally published in Scrip
Executive Summary
French pharma giant Sanofi has confirmed that its CEO Christopher Viehbacher has moved to Boston, Massachusetts. He joins Elias Zerhouni (president of R&D), David-Alexandre Gros (chief strategy officer) and David Meeker (CEO of Sanofi's Genzyme unit), the other members of the 12-person executive committee who are based in the US.